Delivery Order SPE2DB24D3014-SPE2DB25FKULC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 ml syringes with a ceiling value of $1,499.34. The contract was competitively awarded without a set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 22, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,417.28 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atropine 1 mg/10 ml syringes (10 ml quantity). This firm fixed price contract is scheduled for completion by July 30, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation, and the product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,083.52 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 ml syringes on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was awarded without set-aside designation and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,681.81. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The product will be performed and delivered from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes on August 19, 2025, with a ceiling value of $1,270.56 and an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1.74K to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Atropine 8 mg/20 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This delivery order falls...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Atropine 1 mg/ml vials. The contract has a potential value of $1,490.65 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, has provided similar pharmaceutical and medical supply products and services to the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Atropine 1 mg/10 mL in quantities of 10 units. This contract represents a non-set-aside, competitively awarded delivery order with firm fixed price terms and a ceiling value of $21,867.75, with an ultimate completion date of September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKULCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,393.00. The contract, which was competitively awarded without a set-aside designation, is classified as a firm fixed-price delivery order with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio and significant prime IDV position demonstrate its established capability to meet Defense Logistics Agency medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/25/25 |